Skip to main content

Oncology Drugs Market Analysis 2018-2027: Key Findings, Regional Analysis, Key Players Profiles and Future Prospects

Press release   •   Apr 30, 2019 09:32 IST

The global oncology drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading oncology drugs market players and offers key trends and opportunities in the market.

The report analyzes factors affecting oncology drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the oncology drugs market in these regions.

Get PDF sample copy:

The oncology drugs market is anticipated to grow in the forecast period owing to driving factors such as, increasing demand for oncology medications worldwide, growing research activities in cancer diagnosis and rising demand for personalized medicines. Moreover, the worldwide growing geriatric population is anticipated to offer more growth opportunities for the players operating in the oncology drugs market.

Leading Players:

1. Pfizer Inc.
2. Merck & Co., Inc.
3. JOHNSON & JOHNSON (Janssen Global Services, LLC)
4. Novartis AG
5. F. Hoffmann-La Roche Ltd
6. Bristol-Myers Squibb Company
7. AstraZeneca
8. AbbVie Inc.
9. Astellas Pharma Inc.

In the recent years, the increased developments in pharmaceutical industry continue to make cancer more treatable. The rising prevalence of cancer led to rise in demand for cancer drugs worldwide. The oncology drugs are used in the diagnosis of cancer depends upon the stages of the progression. Different types of cancer such as, endocrine cancer, blood cancer, lung cancer, skin cancer, bone cancer, genitourinary cancer, breast cancer, gastrointestinal cancer, head & neck cancer, eye cancer and gynaecologic cancer can be treated by oncology drugs.

Inquire for discount:

The global oncology drugs market is segmented on the basis of drug class type and indication. Based on drug class type, the market is segmented as, chemotherapy, targeted therapy, immunotherapy (biologic therapy) and hormonal therapy. On the basis of indication, the global oncology drugs market is segmented as, lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, kidney cancer, bladder cancer and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global oncology drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oncology drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.

Comments (0)

Add comment


By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.